RecruitingACTRN12605000645651
HPV infection and cervial dysplasia in bone marrow transplant recipients
A study to evaluate the impact of immunosuppression associated with bone marrow transplantation on HPV infection and cervial dysplasia, the impact of conditioning regimens on cytology and the difference in outcome parameters between allogeneic and autologous transplant recipients.
Sponsor
Melbourne Health
Enrollment
82 participants
Start Date
Oct 21, 1998
Study Type
Observational
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- Patients who are about to undergo bone marrow transplantation, either allogeneic or autologous; Patients expected to survive for the 3 year follow up period.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
None
None
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000645651
Related Trials
Shingrix In Recipients of Allogeneic Transplants
NCT057757181 location
Activity Levels in Bone Marrow Transplant Patients
NCT041152411 location
Cardiovascular Risk in Children With Chronic Conditions Study
NCT070869893 locations
Mosaic Trial for Stem Cell Transplant Recipients
NCT069609933 locations
Rehabilitation after bone marrow transplant- what is the impact on patient outcomes? The REBOOT trial
ACTRN126220010717183 locations